KOE:328130

Lunit Inc. · KOE · Healthcare · KRW · FY for 2025

Figures on this page computed 2026-11-08 13:21 UTC

Last close

n/aKRW

Market data

  • n/aP/E

    We do not hold this figure for this company, so there is nothing to place.

    Price / Earnings per Share (diluted)

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed
    • Computed from the filing for 2025
  • -35.3%ROIC

    NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -56.1%Net margin

    Net Income / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • -65.7%FCF margin

    Free Cash Flow / Revenue x 100

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • 0.81Debt/equity

    Total Debt / Shareholders' Equity

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • Computed from the filing for 2025
    • Computed from the filing for 2025
  • n/aDividend yield

    We do not hold this figure for this company, so there is nothing to place.

    Source
    computed
    Taken on
    2026-11-08
    Reported in
    KRW
    • computed

Five bars, one line

lens 7 of 9
3.15x
0.80x
1.35x
3.45x
n/a
SalesProfitFree cash flowDebtPrice
Each bar against this company's own average; the line is that average.
Computed2025
Computed2025
Computed2025
Computed2025
Market datan/a

Each against its own average

4 of 5 read

Except where said otherwise: Computed from the filing for 2025

  • Sales3.15x

    Its own average over 7 years, 26.36B.

  • Profit0.80x

    Its own average over 7 years, -58.48B.

  • Free cash flow1.35x

    Its own average over 7 years, -40.50B.

  • Debt3.45x

    Its own average over 7 years, 32.36B.

  • Pricen/a

    Its own average over 0 years. Market data

Debt is furthest from its own average, at 3.45 times.

Sales is 3.15 times its own 7-year average; Profit is 0.80 times its own 7-year average; Free cash flow is 1.35 times its own 7-year average; Debt is 3.45 times its own 7-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

  • Sales against its own 7-year average3.15
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Profit against its own 7-year average0.80
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Free cash flow against its own 7-year average1.35
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Debt against its own 7-year average3.45
    Source
    computed
    Statement
    income
    Fiscal year
    2025
    Reported in
    KRW
  • Price against its own 0-year averagen/aMarket data

    Not held.

    Source
    market
    Reported in
    KRW

Filed figures cite the filing they come from; figures marked Market data are quotes as of the date shown. Not a recommendation and not advice.

Past figures are not a forecast. Anything we modelled is labelled as ours. You can lose money on any security.